Creating Organs with 3D Printing Technology
With the ability to print functional organs, the 3D printing technology is reshaping the traditional diagnostic practices.
FREMONT, CA: Progressions of the technological renaissance have catalyzed the creative brains of developers and innovators. Enriching the technological ecosystem brought unimaginable inventions, which changed the foundational parameters of various industries. One such technology that bridged the gap between fiction and reality is 3D printers. From logistics to healthcare, 3D printing technology have unraveled and redesigned the traditional functionalities of every sector.
With the ability to efficiently duplicate a functional thing, 3D printing technology has created a strong rapport in the healthcare ecosystem. Furthermore, the fictional outlooks of replicating technology have compelled various clinical researchers and doctors to study their unknown characteristics.
The idea of printing practical organs was fueled by the integration of 3D printing technology in the clinical framework. As farfetched of an idea as it may sound, in today’s world, the doctors can print functional human organs with the help of 3D printers or bioprinters. Custom-built 3D printers have the potential to build not only fully functional organs but also create hybrid structures with improved efficiency.
Using the modeling platform to scan organic objects, the doctors can now detect the micro-abnormalities without performing the operation. Furthermore, the structural and functional parallelism from the 3D printing technology acts as a perfect test subject before the actual procession is taken place. However, it increases the cost of operation, but it also elevates the rate of successful surgeries.
During the inception, 3D printer technology was used to construct materialistic products which involved plastics and wax coatings. However, with the recent emergence of biocompatible plastics, the idea to develop a human cell has come to reality. The organic gel containing proteins promotes the growth of functional tissues, which enhances the effectiveness of creating a utilitarian substitute for the original product.
With the same ability as that of a human organ, the bioprinted organs are being utilized for drug discoveries and clinical trials. Realistic models of perfect cellular functions are further minimizing the failure rates of pharmaceutical research institutes and drug developing enterprises. The post-bioprinting era is looking to show great potential in tissue engineering and the field of grafting.
By Tom Conophy, CIO, Staples Inc.
By Joe Touey, SVP, GSK North America Pharmaceuticals IT
By Eric Tamblyn, Global VP-Guru Managed Services, Genesys
By Charlie Isaacs, CTO, IoT, Salesforce
By Jonathan Rosenberg, VP & CTO, Collaboration, Cisco
By Dave Doyle, CIO & SVP, IT, Regal Entertainment Group
By Jeffrey Keisling, CIO and SVP, Pfizer
By Colin Boyd, VP & CIO, Joy Global Inc
By George Hines, CIO, Massage Envy
By Mark Jacobsohn, SVP, Booz Allen Hamilton
By Mike Gioja, CIO and SVP of IT, Product Management and...
By Nathan Johnson, SVP and CIO, Werner Enterprises [NASDAQ:...
By Darrell Edwards, SVP and Chief Supply Chain Officer,...
By Hannah Datz, VP Retail North America, SAP Hybris
By Marc Kermisch, VP & CIO, Red Wing Shoe Co.
By Robert Garrison, CIO, DTCC
By Mike Sakamoto, CTO, California Department of Health Care...
By Bradley Peterson, EVP & CIO, NASDAQ
By Steve Betts, SVP and CIO, Blue Cross and Blue Shield and...
By Kathryn Kai-ling (Ho) Frederick, EVP, Growth & Insights,...